These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22873800)

  • 1. The relationship between changes in health behaviour and initiation of lipid-lowering and antihypertensive medications in individuals at high risk of ischaemic heart disease.
    Hempler NF; Krasnik A; Pisinger C; Jørgensen T
    BMC Public Health; 2012 Aug; 12():626. PubMed ID: 22873800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
    Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study.
    Hardoon SL; Whincup PH; Wannamethee SG; Lennon LT; Capewell S; Morris RW
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):502-8. PubMed ID: 20386311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Only a fraction of patients with ischaemic diseases or diabetes are treated to recommended target values for plasma lipids.
    Siggaard-Andersen N; Freiberg JJ; Nordestgaard BG
    Dan Med J; 2012 Jul; 59(7):A4470. PubMed ID: 22759845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke. An ecological analysis based on Sweden's municipalities.
    Merlo J; Lindberg G; Lindblad U; Lindgren A; Råstam L; Melander A
    Eur J Clin Pharmacol; 1999 Mar; 55(1):69-76. PubMed ID: 10206088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.
    Davis BR; Cutler JA; Gordon DJ; Furberg CD; Wright JT; Cushman WC; Grimm RH; LaRosa J; Whelton PK; Perry HM; Alderman MH; Ford CE; Oparil S; Francis C; Proschan M; Pressel S; Black HR; Hawkins CM
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):342-60. PubMed ID: 8722437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.
    Cybulsky M; Cook S; Kontsevaya AV; Vasiljev M; Leon DA
    BMC Cardiovasc Disord; 2016 Jun; 16():122. PubMed ID: 27255373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Patterns, Nutrition Knowledge, Lifestyle, and Health-Related Quality of Life: Associations with Anti-Hypertension Medication Adherence in a Sample of Australian Adults.
    Khalesi S; Irwin C; Sun J
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):453-462. PubMed ID: 28884295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and exercise intervention in a general population--mediators of participation and adherence: the Inter99 study.
    Toft UN; Kristoffersen LH; Aadahl M; von Huth Smith L; Pisinger C; Jørgensen T
    Eur J Public Health; 2007 Oct; 17(5):455-63. PubMed ID: 17170019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of lipid-lowering therapy in patients with ischaemic heart disease: a register-based study in 3477 patients.
    Kanstrup H; Lassen JF; Heickendorff L; Lauritzen T; Larsen ML
    J Intern Med; 2004 Mar; 255(3):367-72. PubMed ID: 14871460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.
    Korhonen MJ; Pentti J; Hartikainen J; Ilomäki J; Setoguchi S; Liew D; Kivimäki M; Vahtera J
    J Am Heart Assoc; 2020 Feb; 9(4):e014168. PubMed ID: 32019405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
    Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A
    Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual coronary risk in men aged 50-59 years treated for hypertension and hyperlipidaemia in the population: the PRIME study.
    Blacher J; Evans A; Arveiler D; Amouyel P; Ferrières J; Bingham A; Yarnell J; Haas B; Montaye M; Ruidavets JB; Ducimetière P;
    J Hypertens; 2004 Feb; 22(2):415-23. PubMed ID: 15076202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.
    Roman MJ; Howard BV; Howard WJ; Mete M; Fleg JL; Lee ET; Devereux RB
    Hypertension; 2011 Sep; 58(3):367-71. PubMed ID: 21788602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study.
    Chapman RH; Petrilla AA; Benner JS; Schwartz JS; Tang SS
    Drugs Aging; 2008; 25(10):885-92. PubMed ID: 18808213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.
    Law M; Wald N; Morris J
    Health Technol Assess; 2003; 7(31):1-94. PubMed ID: 14604498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.